CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Errico, M.
Right arrow Articles by Dogliotti, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Errico, M.
Right arrow Articles by Dogliotti, E.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 553-559, June 1999
© 1999 American Association for Cancer Research

Factors That Influence the DNA Repair Capacity of Normal and Skin Cancer-affected Individuals

Mariarosaria D’Errico, Angelo Calcagnile, Ivano Iavarone, Francesco Sera, Giannandrea Baliva, Luca M. Chinni, Rosamaria Corona, Paolo Pasquini and Eugenia Dogliotti1

Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanitá, 00161 Rome, Italy [M. D., A. C., E. D.]; Istituto Dermopatico dell’Immacolata, 00167 Rome, Italy [M. D., F. S., G. B., L. C., R. C., P. P.]; and Laboratory of Environmental Hygiene, Istituto Superiore di Sanitá, 00161 Rome, Italy [I. I.]

DNA repair capacity (DRC) was studied in 49 patients affected by basal cell carcinoma (BCC) and 68 cancer-free controls belonging to a larger case-control population enrolled for studying BCC risk factors. DRC was measured in the subjects’ peripheral blood lymphocytes by using a host-cell reactivation assay that measures cellular activation of a reporter gene irradiated with UV light. A statistically significant age-related decline in DRC was observed in the controls from 20 to 70 years of age but not in the BCC cases. When the DRC values of the BCC patients and controls were compared by age, young BCC cases (age, <=40 year) repaired less than the controls, although the difference was not statistically significant. Conversely, older BCC patients (age, >40 years) presented an enhanced repair capacity (P < 0.001) as compared with their controls. The search for possible factors associated with the high repair rate of elderly BCC cases revealed that both target cell physiology and life-style habits may affect host DNA repair. Smoking was the variable that explained most of the increase in DRC among older patients. The understanding of how these factors affect host DRC will be relevant for a correct use of this biomarker.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L.-E Wang, C. Li, S. S. Strom, L. H. Goldberg, A. Brewster, Z. Guo, Y. Qiao, G. L. Clayman, J. J. Lee, A. K. El-Naggar, et al.
Repair Capacity for UV Light Induced DNA Damage Associated with Risk of Nonmelanoma Skin Cancer and Tumor Progression
Clin. Cancer Res., November 1, 2007; 13(21): 6532 - 6539.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. Zijno, F. Saini, and R. Crebelli
Suitability of cryopreserved isolated lymphocytes for the analysis of micronuclei with the cytokinesis-block method
Mutagenesis, September 1, 2007; 22(5): 311 - 315.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Wang, Q. Wei, Q. Shi, Z. Guo, Y. Qiao, and M. R. Spitz
A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma
Carcinogenesis, July 1, 2007; 28(7): 1430 - 1436.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Shen, M. Desai, M. Agrawal, D. O. Kennedy, R. T. Senie, R. M. Santella, and M. B. Terry
Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1614 - 1619.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. O. Kennedy, M. Agrawal, J. Shen, M. B. Terry, F. F. Zhang, R. T. Senie, G. Motykiewicz, and R. M. Santella
DNA Repair Capacity of Lymphoblastoid Cell Lines From Sisters Discordant for Breast Cancer
J Natl Cancer Inst, January 19, 2005; 97(2): 127 - 132.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R.-H. Wong, C.-L. Du, J.-D. Wang, C.-C. Chan, J.-C. J. Luo, and T.-J. Cheng
XRCC1 and CYP2E1 Polymorphisms as Susceptibility Factors of Plasma Mutant p53 Protein and Anti-p53 Antibody Expression in Vinyl Chloride Monomer-exposed Polyvinyl Chloride Workers
Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 475 - 482.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.